Center-Authored Papers

Filters: Author is Kentsis, Alex  [Clear All Filters]
2016
Brown FC, Cifani P, Drill E, He J, Still E, Zhong S, Balasubramanian S, Pavlick D, Yilmazel B, Knapp KM et al..  2016.  Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemia.. British journal of haematology. Abstract
Laszlo GS, Alonzo TA, Gudgeon CJ, Harrington KH, Kentsis A, Gerbing RB, Wang Y-C, Ries RE, Raimondi SC, Hirsch BA et al..  2016.  Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.. Journal of hematology & oncology. 9(1):133.
Sabath DE, Bender MA, Sankaran VG, Vamos E, Kentsis A, Yi H-S, Greisman HA.  2016.  Characterization of Deletions of the HBA and HBB Loci by Array Comparative Genomic Hybridization.. The Journal of molecular diagnostics : JMD. 18(1):92–99. Abstract
2015
Laszlo GS, Alonzo TA, Gudgeon CJ, Harrington KH, Kentsis A, Gerbing RB, Wang Y-C, Ries RE, Raimondi SC, Hirsch BA et al..  2015.  High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.. Journal of hematology & oncology. 8(1):115. Abstract